Boston Scientific (MEX:BSX) Cyclically Adjusted Book per Share: MXN212.34 (As of Mar. 2026)


MEX:BSX Boston Scientific Corp MEX:BSX
85 GF Score
Price MXN784.12
GF Value MXN1,834.19
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Cyclically Adjusted Book per Share?

Boston Scientific MEX:BSX 85 Cyclically Adjusted Book per Share is MXN212.34 as of Mar. 2026. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,834.19 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Boston Scientific's adjusted book value per share for the three months ended in Mar. 2026 was MXN313.799. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN212.34 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Boston Scientific's average Cyclically Adjusted Book Growth Rate was 12.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Boston Scientific was 25.70% per year. The lowest was -6.70% per year. And the median was 10.80% per year.

As of today (2026-07-05), Boston Scientific's current stock price is MXN784.12. Boston Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was MXN212.34. Boston Scientific's Cyclically Adjusted PB Ratio of today is 3.69.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Boston Scientific was 10.37. The lowest was 2.65. And the median was 5.82.


Boston Scientific  (MEX:BSX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Boston Scientific's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=784.12/212.34
=3.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Boston Scientific was 10.37. The lowest was 2.65. And the median was 5.82.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Boston Scientific Cyclically Adjusted Book per Share Related Terms


Boston Scientific Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Cyclically Adjusted Book per Share Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 154.12 165.83 151.19 210.74 205.83

Boston Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 216.10 203.70 204.93 205.83 212.34

MEX:BSX vs EW, GEHC, MDT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted PB Ratio falls into.


MEX:BSX
85GF Score
Boston Scientific Corp MEX:BSX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Boston Scientific's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=313.799/330.2130*330.2130
=313.799

Current CPI (Mar. 2026) = 330.2130.

Boston Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201606 84.662 241.018 115.993
201609 92.059 241.428 125.914
201612 101.912 241.432 139.388
201703 97.000 243.801 131.380
201706 95.427 244.955 128.641
201709 100.316 246.819 134.210
201712 100.250 246.524 134.282
201803 92.562 249.554 122.479
201806 110.160 251.989 144.357
201809 112.051 252.439 146.573
201812 123.731 251.233 162.628
201903 128.782 254.202 167.290
201906 130.090 256.143 167.709
201909 137.366 256.759 176.664
201912 187.623 256.974 241.097
202003 231.311 258.115 295.922
202006 252.206 257.797 323.051
202009 240.124 260.280 304.641
202012 215.220 260.474 272.843
202103 226.200 264.877 281.996
202106 223.210 271.696 271.284
202109 237.568 274.310 285.983
202112 239.214 278.802 283.325
202203 233.090 287.504 267.716
202206 242.727 296.311 270.498
202209 247.781 296.808 275.668
202212 239.037 296.797 265.950
202303 223.817 301.836 244.859
202306 213.627 305.109 231.204
202309 224.563 307.789 240.924
202312 223.291 306.746 240.373
202403 224.952 312.332 237.830
202406 253.710 314.175 266.661
202409 276.731 315.301 289.819
202412 307.909 315.605 322.161
202503 307.205 319.799 317.209
202506 285.145 322.561 291.909
202509 289.528 324.800 294.353
202512 294.210 324.054 299.802
202603 313.799 330.213 313.799

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN212.34 mean?
Boston Scientific (MEX:BSX) has a Cyclically Adjusted Book per Share of MXN212.34 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Cyclically Adjusted Book per Share too high?
Boston Scientific's current Cyclically Adjusted Book per Share is MXN212.34. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Cyclically Adjusted Book per Share compare to EW and GEHC?
Boston Scientific's Cyclically Adjusted Book per Share of MXN212.34 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Boston Scientific and its competitors. Boston Scientific's current Cyclically Adjusted Book per Share is MXN212.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,834.19, compared to a current price of MXN784.12 — trading 57.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is MXN212.34. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Cyclically Adjusted Book per Share is MXN212.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (MEX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of MXN784.12 is trading 57.2% below its estimated GF Value™ of MXN1,834.19. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for MEX:BSX:

  • Cyclically Adjusted Book per Share: MXN212.34
  • GF Value™: MXN1,834.19 vs. price of MXN784.12 (57.2% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score

Get the complete analysis for MEX:BSX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN784.12
Price
MXN1,834.19
GF Value